1232
L. Liu et al. / Chinese Chemical Letters 23 (2012) 1230–1232
The in vitro antitumor activities of the prepared compounds were tested against HeLa, MCF-7 and A549 cells with
harmine as positive controls. The results were summarized in Table 1. It showed that some of the compounds displayed
enhanced anti-tumor potency over harmine against HeLa and MCF-7 cell lines. However, the compounds with electro-
withdrawing substituents in phenyl group at C4-position displayed lower anti-tumor activity against HeLa and MCF-7
cells. A general trend is that compounds with an electro-donating group in phenyl group at C4-position have better
activity against these three cell lines than electro-withdrawing group. In addition, all target compounds showed anti-
tumor activity against A549 cell line.
In summary, we have synthesized a series of novel 4-substituted 3-phenyl-b-carbolines by several steps. Some of
the compounds showed better in vitro inhibitory activity against HeLa and MCF-7 than reference harmine. The further
synthesis and biological study for the similar novel carboline analogs are underway in our laboratory.
Acknowledgments
This work was supported by NSFC (No. 20602010), Scientific Research Fund of Hunan Provincial Education
Department (No. 10B061) and Program for Science and Technology Innovative Research Team in Higher Educational
Institutions of Hunan Province.
References
[1] M. Rosillo, A. Gonzalez-Gomez, G. Dominguez, et al. Targets Heterocycl. Syst. 12 (2008) 212.
[2] M. Hesse (Ed.), Alkaloids: Nature’s Curse or Blessing, Helvetica Chimica Acta/Wiley-VCH, Zu¨rich, 2002.
[3] T. Ohmoto, K. Koike, in: A. Brossi (Ed.), The Alkaloids, vol. 36, Academic Press, San Diego, 1989, p. 135.
[4] R. Cao, W. Peng, Z. Wang, Curr. Med. Chem. 14 (2007) 479.
[5] J. Ishida, H.K. Wang, K.F. Bastow, et al. Bioorg. Med. Chem. Lett. 9 (1999) 3319.
[6] B.E. Love, Org. Prep. Proced. Int. 28 (1996) 1.
[7] E.D. Cox, J.M. Cook, Chem. Rev. 95 (1995) 1797.
[8] K. Pulka, Curr. Opin. Drug Discov. Devel. 13 (2010) 669.
[9] H. Zhang, R.C. Larock, Org. Lett. 3 (2001) 3083.
[10] S. Ding, Z. Shi, N. Jiao, Org. Lett. 12 (2010) 1540.
[11] M.B. Joydev, A.R. Silvia, Roberto, et al. J. Org. Chem. 76 (2011) 6421.
[12] G. Verniest, D. England, N. De Kimpe, et al. Tetrahedron 66 (2010) 1496.
[13] D. Fischer, H. Tomeba, N.K. Pahadi, et al. J. Am. Chem. Soc. 130 (2008) 15720.
[14] Selected data of title compounds: 1a: off-white solid, mp 202.5–204 8C; 1H NMR (500 MHz, CDCl3): d 6.94 (t, 1H, J = 7.50 Hz, ArH), 7.02 (d,
1H, J = 8.00 Hz, ArH), 7.08 (d, 1H, J = 8.00 Hz, ArH), 7.20–7.24 (m, 3H, ArH), 7.33–7.44 (m, 8H, ArH), 9.19 (s, 1H, ArH), 10.00 (s, 1H, NH);
13C NMR (CDCl3): d 111.62, 119.55, 121.64, 123.44, 126.71, 127.58, 127.68, 127.98, 128.53, 130.05, 130.25, 130.36, 132.07, 135.30, 138.06,
140.74, 141.32, 147.30; MS (EI) 320 (M++1), 319 (100), 277, 169, 69, 57; Anal. Calcd. for C23H16N2: C, 86.22; H, 5.03; N, 8.74. Found: C,
86.40; H, 4.90; N, 8.70. 1e: off-white solid, mp: 198–199.5 8C; 1H NMR (500 MHz, CDCl3): d 0.34–0.37 (m, 2H, CH2), 1.03–1.07 (m, 2H,
CH2), 2.47–2.52 (m, 1H, CH), 7.27 (s, 1H, ArH), 7.31 (t, 1H, J = 7.50 Hz, ArH), 7.39 (t, 1H, J = 7.25 Hz, ArH), 7.46 (t, 2H, J = 7.50 Hz, ArH),
7.52 (t, 1H, J = 7.50 Hz, ArH), 7.76 (d, 2H, J = 7.50 Hz, ArH), 8.57 (d, 1H, J = 8.00 Hz, ArH), 8.96 (s, 1H, ArH), 9.44 (s, 1H, NH); 13C NMR
(CDCl3): d 10.58, 14.18, 21.06, 111.44, 119.68, 121.94, 125.20, 126.96, 127.78, 129.47, 129.97, 130.77, 131.06, 135.05, 141.07, 141.94,
149.96, 171.20; MS (EI) 285 (M++1): 269, 256, 159, 127, 121, 97, 83, 71, 57 (100), 43; Anal. Calcd. for C20H16N2: C, 84.48; H, 5.67; N, 9.85.
Found: C, 84.30; H, 5.89; N, 9.45.